名古屋BMTグループ業績集
著書
- 名古屋骨髄移植グループ:造血幹細胞移植マニュアル.森下剛久、堀部敬三、森島泰雄編.小寺良尚、齋藤英彦監修.日本医学館、1995
- 名古屋骨髄移植グループ:造血幹細胞移植マニュアル第2版.森下剛久、堀部敬三、山田博豊、森島泰雄編.小寺良尚、齋藤英彦監修.日本医学館、1998
- 名古屋BMTグループ:造血幹細胞移植マニュアル第3版.森下剛久、森島泰雄、堀部敬三、佐尾 浩、濱口元洋、松山孝治編.小寺良尚、齋藤英彦監修.日本医学館、2004
原著
- Kodera Y, Morishima Y, Morishita Y, Murase T, Okumura M, Yamada H, Minami S, Kato Y, Ogura M, Nagura E, et al.: Sixteen adult patients with acute leukemia treated by chemotherapy, total body irradiation and allogeneic marrow transplantation. Jpn J Clin Oncol 14 (Suppl 1): 479-485, 1984
- 平林憲之、矢野邦夫、横幕省三、森島泰雄、岩村春樹、内藤和行、小寺良尚、松山孝治、中出泰充、山田博豊、名古屋骨髄移植グループ:同種骨髄移植を行った急性白血病91例の治療成績.臨床血液 29: 313-319, 1988
- Morishima Y, Morishita Y, Tanimoto M, Ohno R, Saito H, Horibe K, Hamajima N, Naito K, Yamada K, Yokomaku S, Hirabayashi N, Yamada H, Nakaide Y, Kojima S, Minami S, Matsuyama K, Kodera Y and Nagoya Bone Marrow Transplantation Group: Low incidence of acute graft versus host disease by the administration of methotrexate and cyclosporine in Japanese leukemia patients after bone marrow transplantation from human leukocyte antigen compatible siblings; possible role of genetic homogeneity. Blood 74: 2252-2256, 1989
- 山田博豊、竹山英夫、安部明弘、渡辺英二、小寺良尚、松山孝治、平林憲之、森島泰雄、内藤和行、中出泰充、堀部敬三、横幕省三、名古屋骨髄移植グループ:白血病骨髄移植120例における間質性肺炎の検討.臨床血液 30: 1937-1942, 1989
- 赤塚美樹、南三郎、小寺良尚、平林憲之、森島泰雄、森下剛久、内藤和行、山内辰也、中出安充、横幕省三、山田博豊、祖父江良:寛解期(慢性期)成人白血病に対する同種骨髄移植75例における graft-versus-host disease (GVHD)予防法(methotrexate単独、cyclosporine A単独、methotrexate + cyclosporone A)の比較検討.移植 25 : 635-642, 1990
- 矢崎 信、宮村耕一、小島勢二、小寺良尚、平林憲之、堀部敬三、森島泰雄、和田義郎:Ph1陽性急性リンパ性白血病の骨髄移植.臨床血液 32: 851-854, 1991
- Akatsuka Y, Kodera Y, Yamamoto K, Minami S, Miyamura K, Morishita Y, Morishima Y, Saitoh H, Horibe K, Yamauchi T, Nagoya Bone Marrow Transplantation Group (NBMTG), Tokai Marrow Donor Bank (TMDB): Bone marrow transplantation for chronic myelogenous leukemia in blastic phase using a phenotypically identical unrelated volunteer donor. Int J Hematol 55: 249-253, 1992
- Morishima Y, Miyamura K, Kojima S, Ueda R, Morishita Y, Sao H, Tanimoto M, Ohno R, Sobue R, Hirano M, Sakamaki H, Takamoto S, Imai K, Onozawa Y, Yokomaku S, Kato Y, Tsuzuki S, Akatsuka Y, Minami S, Matsuyama T, Kodera Y, Takahashi T, Saito H and Nagoya Bone Marrow Transplantation Group: Autologous BMT in high-risk patients woth CALLA-positive ALL : possible efficacy of ex vivo marrow leukemia cell purging with monoclonal antibodies and complement. Bone Marrow Transplant 11:255-259, 1993
- 松本公一、堀部敬三、赤塚美樹、南 三郎、松山孝治、平林憲之、谷本光音、山田博豊、祖父江良、森島泰雄、小寺良尚、名古屋骨髄移植グループ、東海骨髄バンク:HLA適合同胞以外のドナーによる骨髄移植:造血器腫瘍114例の成績.臨床血液 35: 729-737, 1994
- Morishima Y, Kodera Y, Hirabayashi N, Tanimoto M, Matsuyama T, Horibe K, Ohta H, Mizuno S, Morishita Y, Yamaguchi T, Yamada H, Sobue R, Shiobara S, Minami S, Goto S, Ogawa K, Hamajima N, Saito H and the Tokai Marrow Donor Bank: Low incidence of acute GVHD in patients with marrow from HLA-A, B, DR-compatible unrelated donors among Japanese. Bone Marrow Transplant 15: 235-239, 1995
- Hirabayashi N, Kodera Y, Matsuyama T, Tanimoto M, Horibe K, Naoe T, Kojima H, Yamada H, Utsumi M, Morishima Y, et al: Bone marrow transplantation in 614 patients: twenty year experience of the Nagoya Bone Marrow Transplantation Group (NBMTG). Transplant Proc 27: 1380-1382, 1995
- Mizuno S, Ohta H, Kamijima S, Kato Y, Maruya E, Saji H, Kamiya T, Kodera Y, Morishima Y for the Nagoya Bone Marrow Transplantation Group and Tokai Marrow Donor Bank: Genotyping analysis of HLA-class II and III genes in unrelated bone marrow transplantation among Japanese. Transplant Proc 27: 1383-1384, 1995
- 鈴木律朗、加藤剛二、平林憲之、赤塚美樹、堀部敬三、久保和明、祖父江良、中原洋介、山田博豊、南 三郎、小島勢二、後藤整一、谷本光音、松本公一、直江知樹、小島博嗣、内海 真、横幕省三、森下剛久、仁田正和、矢崎 信、永田紘一郎、矢野邦夫、森島泰雄、松山孝治、小寺良尚:名古屋骨髄移植グループにおける骨髄移植749例の検討.今日の移植 8: 57-64, 1995
- 森島泰雄、谷本光音、小寺良尚、宮脇修一、平林憲之、朝長万左夫、小島博嗣、小林 透、小野沢康輔、仁田正和、椿 和央、山田博豊、平岡 諦、浜島信之、大野竜三、名古屋骨髄移植グループ、Japan Adult Leukemia Study Group:HLA適合同種骨髄移植の成績とその限界:急性骨髄性白血病第1寛解期における骨髄移植成績と化学療法成績の比較.臨床血液 36: 517-523, 1995
- Kodera Y, Morishima Y, Hirabayashi N, Tanimoto M, Matsuyama T, Horibe K, Mizuno S, Morishita Y, Yamaguchi T, Yamada H, Sobue R, Shiobara S, Hamajima N, Kitaori K, Yazaki M, Nitta M, Saito H and Tokai Marrow Donor Bank: Analysis of 55 transplantations from unrelated Volunteer donors facilitated by Tokai Marrow Donor Bank. Intern Med 35: 78-83, 1996
- 森下剛久、堀部敬三ら:Meeting report: The First Nagoya International Blood and Marrow Transplantation Symposium: New trend in hematopoietic stem cell transplantation. 今日の移植 9: 679-694, 1996
- Hamaguchi M, Yamada H, Morishima Y, Morishita Y, Kato Y, Sao H, Kanie T, Murata M, Taji H, Nakayama Y, Minami S, Saito H, Kodera Y: Serum thrombopoietin level after allogeneic bone marrow transplantation: possible correlation with platelet recovery, acute graft-versus-host disease and hepatic veno-occlusive disease. Int J Hematol 64: 241-248, 1996
- Yokoi T, Hirabayashi N, Ito M, Uno Y, Tsuzuki T, Yatabe Y, Kodera Y for the Nagoya BMT Group: Broncho-bronchiolitis obliterans as a complication of bone marrow transplantation: a clinicopathological study of eight autopsy cases. Virchows Arch 431: 275-282, 1997
- 平林憲之、後藤整一、森島泰雄、佐尾 浩、松山孝治、小寺良尚、山田博豊、堀部敬三、矢野邦夫、小島博嗣、小椋美知則、谷本光音、森下剛久、矢崎 信、内海 真、永田紘一郎、加藤芳郎、直江知樹、齋藤英彦:Granisetronの造血細胞移植前処置における制吐効果.臨床血液 39: 21-26, 1998
- Mizuta S, Ito Y, Kohno A, Kiyoi H, Miyamura K, Tanimoto M, Takamatsu J, Naoe T, Morishima Y, Ueda R, Saito H: Accurate quantitation of residual tumor burden at bone marrow harvest predicts timing of subsequent relapse in patients with common ALL treated by autologous bone marrow transplantation. Nagoya BMT Group. Bone Marrow Transplant 24: 777-784, 1999
- Morishita Y: Third Nagoya International Blood and Marrow Transplantation Symposium: Challenge for the stem cell therapy. Int J Hematol 71:188-191, 2000
- Yano K, Kanie T, Okamoto S, Kojima H, Yoshida T, Murata I, Dohi H, Morishita Y, Ozawa K, Sao H, Sakamaki H, Hiraoka S, Imoto S, Morishima Y, Kodera Y: Quality of life in adult patients after stem cell transplantation. Int J Hematol 71: 283-289, 2000
- Miyamura K, Hamaguchi M, Taji H, Kanie T, Kohno A, Tanimoto M, Saito H, Kojima S, Matsuyama T, Kitaori K, Nagafuji K, Sato T, Kodera Y: Successful ribavirin therapy for severe adenovirus hemorrhagic cystitis after allogeneic marrow transplant from close HLA donors rather than distant donors. Bone Marrow Transplant 25: 545-548, 2000
- Sao H, Kato C, Kitaori K, Adachi T, Yano K, Kobayashi M, Kojima H, Tanimoto M, Hirabayashi N, Minami S, Yamada H, Morishita Y, Morishima Y, Kodera Y: Effective and safe interferon treatment for Japanese patients with chronic myelogenous leukemia relapse after bone marrow transplantation. Int J Hematol 72: 237-242, 2000
- Murata M, Emi N, Hirabayashi N, Hamaguchi M, Goto S, Wakita A, Tanimoto M, Saito H, Kodera Y, Morishita Y, Nagoya Blood and Marrow Transplantation Group: No significant association between HA-1 incompatibility and incidence of acute graft-versus-host disease after HLA-identical sibling bone marrow transplantation in Japanese patients. Int J Hematol 72: 371-375, 2000
- Murata M, Emi N, Hirabayashi N, Hamaguchi M, Goto S, Wakita A, Tanimoto M, Saito H, Kodera Y, Morishita Y: No significant association between HA-1 incompatibility and incidence of acute graft-versus-host disease after HLA-identical sibling bone marrow transplantation in Japanese patients. Int J Hematol 72: 371-375, 2000
- Sao H, Morishita Y: The Fourth Nagoya International Blood and Marrow Transplantation Symposium: New horizons in allogeneic hematopoietic cell transplantation. – 2001 revolution. Int J Hematol 75: 213-217, 2002
- Yanada M, Yamamoto K, Emi N, Naoe T, Suzuki R, Taji H, Iida H, Shimokawa T, Kohno A, Mizuta S, Maruyama F, Wakita A, Kitaori K, Yano K, Hamaguchi M, Hamajima N, Morishima Y, Kodera Y, Sao H, Morishita Y for the Nagoya BMT Group: Cytomegalovirus antigenemia and outcome of patients treated with preemptive ganciclovir: retrospective analysis of 241 consecutive patients undergoing allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 32: 801-807, 2003
- Iida H, Sao H, Kitaori K, Gotoh S, Yazaki M, Kojima S, Wakita A, Morishima Y, Kodera Y, Morishita Y: Twenty years’ experience in allogeneic hematopoietic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia in the Nagoya Blood and Marrow Transplantation Group. Int J Hematol 79: 79-84, 2004
- Nishida T, Hamaguchi M, Hirabayashi N, Haneda M, Terakura S, Atsuta Y, Imagama S, Kanie T, Murata M, Taji H, Suzuki R, Morishita Y, Kodera Y: Intestinal thrombotic microangiopathy after allogeneic bone marrow transplantation: a clinical imitator of acute enteric graft-versus-host disease. Bone Marrow Transplant 33: 1143-1150, 2004
- Shimada K, Yokozawa T, Atsuta Y, Kohno A, Maruyama F, Yano K, Taji H, Kitaori K, Goto S, Iida H, Morishima Y, Kodera Y, Naoe T, Morishita Y: Solid tumors after hematopoietic stem cell transplantation in Japan: incidence, risk factors and prognosis. Bone Marrow Transplant 36: 115-121, 2005
- Atsuta Y, Suzuki R, Yamamoto K, Terakura S, Iida H, Kohno A, Naoe T, Yano K, Wakita A, Taji H, Hamaguchi M, Kodera Y, Sao H, Morishima Y, Hamajima N, Morishita Y: Risk and prognostic factors for Japanese patients with chronic graft-versus-host disease after bone marrow transplantation. Bone Marrow Transplant 37: 289-296, 2006
- Kohno A, Morishita Y, Iida H, Sakamaki H, Yokozawa T, Kitaori K, Ozeki K, Matsuo K, Sao H: Low-dose cyclosporin A with short-term methotrexate for graft-versus-host disease prophylaxis in allogeneic bone marrow transplantation from human leukocyte antigen-identical siblings: a prospective phase II study in Japanese patients. Int J Hematol 84: 83-89, 2006
- Mizuta S, Kohno A, Morishita Y, Atsuta Y, Sao H, Miyamura K, Sakamaki H, Ueda R, Morishima Y: Long-term follow-up of 14 patients with Philadelphia chromosome-positive acute lymphoblastic leukemia following autologous bone marrow transplantation in first complete remission. Int J Hematol 85:140-145, 2007.
- Inamoto Y, Nishida T, Suzuki R, Miyamura K, Sao H, Iida H, Naoe T, Maruyama F, Hirabayashi N, Hamaguchi M, Iseki T, Kami M, Yano K, Takeyama H, Morishita Y, Morishima Y, Kodera Y.: Significance of additional high-dose cytarabine in combination with cyclophosphamide plus total body irradiation regimen for allogeneic stem cell transplantation. Bone Marrow Transplant 39: 25-30, 2007
- Narimatsu H, Terakura S, Matsuo K, Oba T, Uchida T, Iida H, Hamaguchi M, Watanabe M, Kohno A, Murata M, Sawa M, Miyamura K, Morishita Y: Short-term methotrexate could reduce early immune reactions and improve outcomes in umbilical cord blood transplantation for adults. Bone Marrow Transplant 39: 31-39, 2007
- Narimatsu H, N Emi N, Kohno A, Iwai M, Yanada M, Yokozawa T, Saito S, Shimada K, Kiyoi H, Naoe T, Yamamoto K and Morishita Y: High incidence of secondary failure of platelet recovery after autologous and syngeneic peripheral blood stem cell transplantation in acute promyelocytic leukemia. Bone Marrow Transplant 40: 773-778, 2007
この業績集に関して、お気づきの点がありましたら、執行部までご連絡願います。